There are about 37.3 million people, or 1 in 10, in the United States who have diabetes, according to the Centers for Disease Control and Prevention. Reed Saxon AP Eli Lilly plans to slash the cost of ...
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients can ...
Hunter Sego, 26, of Indiana, had been spending about $660 each month on insulin from the drugmaker Eli Lilly. When the company announced earlier this month that it would be capping the out-of-pocket ...
Eli Lilly plans to sell two versions of its Humalog insulin at half the list price starting in mid-April, the drugmaker said Jan. 14. It will create two generic versions of its Humalog Kwikpens that ...
Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as of ...
California Gov. Gavin Newsom has announced a new contract with nonprofit drugmaker Civica Rx, a move that brings the state one step closer to creating its own line of insulin to bring down the cost of ...
April 15 (Reuters) - A settlement between Eli Lilly (LLY.N), opens new tab and purchasers of its insulin drugs that would have capped prices and provided $13.5 million to resolve claims that the ...
This March 1, 2023, photo shows a vial of Eli Lilly's Humalog insulin in New York. (AP Photo/Pablo Salinas) AUSTIN, Texas (CN) — Texas sued drugmakers and pharmacy benefit managers Thursday, claiming ...
Non inferior HbA1c reduction at 26 weeks (primary endpoint) Significant reduction of the rise of blood glucose after a test meal (key secondary endpoints) Mean blood glucose level over the day ...
The insulin price drop announced last week by Eli Lilly was good news for the half million people in Massachusetts with diagnosed diabetes. The company announced Wednesday that it would lower the ...
Novo Nordisk A/S, one of the world’s biggest makers of insulin, said it would cut US prices for several of its products by up to 75%, following similar actions by rival Eli Lilly & Co. Novo will ...
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback